- Pediatric orthopedics company OrthoPediatrics ( NASDAQ: KIDS ) issued Q4, FY22 and FY23 guidance below consensus.
- The company said its Q4 net revenue is expected to be $31M, vs. consensus of $33.18M, represents a growth of 25% Y/Y.
- The Q4 domestic net revenue growth is expected to be 15% Y/Y, while international net revenue growth is expected to be 67% Y/Y.
- FY22 net revenue is expected to be $122.3M, vs. consensus of $124.48M.
- The FY22 net revenue represents a growth of 25% Y/Y.
- The FY22 domestic net revenue growth is expected to be 19%, while international net revenue growth is expected to be 47%.
- FY23 net revenue is projected to be in the range of $146M to $149M, vs. consensus of $151.82M.
- The FY23 net revenue represents a growth of 20% to 22% Y/Y.
- KIDS shares were trading ~6% down post-market.
- Source: Press Release
For further details see:
OrthoPediatrics issues Q4, FY22, FY23 guidance below consensus